Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors.
Babar BashirJudy S WangGerald S FalchookElisa FontanaHendrick-Tobias ArkenauLouise CarterRachel GalotBristi BasuAlastair P GreystokeVivek SubbiahDebra L RichardsonHanna OrrGavin BennettRajiv SharmaHongmei XuPaola PaganoniCong XuCarly CampbellMeredith A McKeanPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
once every 2 weeks.